您的位置：PharmaNews → 研发动态 → 正文
内容搜索
热门内容
推荐内容
最新内容
反馈意见和建议

deCODE Shows how Genetic Risk of Kidney Disease Frames Response to Environmental Risk Over Time(2)
     添加时间:2010-08-02    原文发表:2010-08-02    人气:33
本文章共2151字，分2页，当前第2页，快速翻页：


 


   
    Contacts:
    Edward Farmer
    +44(0)7796-010107
    edward.farmer@decode.is
    Gisli Arnason
    +354-570-1900
    info@decode.is

Source: DeCODE Genetics Inc

Contacts: Edward Farmer, +44(0)7796-010107, edward.farmer@decode.is; Gisli Arnason, +354-570-1900, info@decode.is
 

转载自pharmaLive

本文章更多内容：<<上一页 - 1 - 2

 

 

点这里复制本页地址     发送给您QQ/MSN上的好友


相关文章

•  New pathway to Parkinson's and Alzheimer

•  Plant Compound Resveratrol Shown to Supp

•  WaferGen Announces Purchase of SmartChip

•  Researchers Solve Mystery of Uner Tan Sy

•  Shionogi Inc. Announces FDA Approval of

•  Abraxis BioScience and Specialised Thera

•  Abbott's Simcor ( niacin extended-releas

•  FDA Approves Drug for Chronic Drooling i

•  Quintiles Announces New European Headqua

•  Covance Reports Second Quarter Revenue o

Bionovo to Advance Menerba to Phase 3 Cl

Geron to Proceed with First Human Clinic

Orexigen Therapeutics Announces Publicat

Basilea Pharmaceutica AG (CH) - Data on

Study Results Show That Oral Contracepti

勃林格殷格翰糖尿病药物linagliptin一项Ⅲ期

厄洛替尼在欧盟提交申请用于具EGFR 活化突变

诺华公司肾癌治疗药物依维莫司新适应证研究

罗氏发布在研糖尿病药taspoglutide的Ⅲ期临

罗氏正式提交赫赛汀第二代共轭化合物曲妥珠

相关评论

    
本文章所属分类：首页 → 研发动态